Contract facts
FederalNo full NAICS 621991 intel page yet. Browse NAICS intelligence
BLOOD DONOR TESTING MAMC is a federal award for W40m Mrco Pacific held by Bloodworks. Estimated value $845K ($845K obligated). Current period of performance ends Feb 28, 2027. Place of performance: JOINT BASE LEWIS MCCHORD WA.
Recompete timing
PublicCurrent PoP ends Feb 28, 2027 (191 days remaining). Agencies typically plan 12–18 months ahead — at 6.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordBloodworks — $16.4M obligated across 30 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0226FA036?
W81K0226FA036 (BLOOD DONOR testing MAMC) is a W40m Mrco Pacific award with a potential value of $845K, currently held by Bloodworks. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded W81K0226FA036?
W40m Mrco Pacific awarded W81K0226FA036 to Bloodworks (potential $845K).
Who is the incumbent on W81K0226FA036?
Bloodworks is the incumbent with $16.4M across 30 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2027.
When does Bloodworks’s W81K0226FA036 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
